Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06519409
Status:
COMPLETED
Last Update Posted:
None
First Post:
2023-07-26
Brief Title:
Comparison of Bone Graft and Photodynamic Therapy in Class II Furcation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparative Treatment Evaluation of Human Mandibular Class II Furcation Defects Using Bone Grafts and Antimicrobial Photodynamic Therapy-A Randomized Control Trial
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a surgical comparative clinical trial which aims to assess class II buccal furcation defects treated with Xenograft alone or preceded by antimicrobial photodynamic therapy
Detailed Description:
To test the efficacy of photodynamic therapy Indocyanine green along with placement of xenograft Cerabone-Natural bovine bone grafting material Botiss biomaterials to treat a class II furcation defects The topical study was designed as a randomized controlled single blinded patient split mouth clinical trial with 14 participants In the control group the defects were filled with xenograft Cerabone whereas the test group received photodynamic therapy Indocyanine green in addition to grafting Radiovisiography technique was used to observe the possible changes in the furcation region at baseline and 9 months postoperatively
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: